This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Phototherapy Treatment Market

Market Insights on Phototherapy Treatment covering sales outlook, demand forecast & up-to-date key trends

Phototherapy Treatment Market By Disease Type (Psoriasis, Acne), Phototherapy (Blue Light Phototherapy, Red Light Phototherapy, Intense Pulsed Light (IPL) Phototherapy), End User (Hospitals, Dermatology Clinics/Skin Care Centres, Wellness Centres) & Region - Forecast 2021 - 2027

Phototherapy Treatment Market Overview

[102 Pages Report] The phototherapy treatment market is valued at US$ 530 Million in 2021. The market is likely to grow at a CAGR of 5% through 2026, reaching US$ 675 Million.

Attribute

Details

Estimated Market Size of Phototherapy Treatment Market in 2021

US$ 530 Mn

Projected Market Size of Phototherapy Treatment Market in 2026

US$ 675 Bn

CAGR during 2021-2022

5%

Through 2027, the phototherapy treatment market in North America and Europe is predicted to grow at a CAGR of 6% reaching US$ 1 Billion.

The USA presently controls 35% of the revenue in the North American phototherapy treatment market. The market for Acne and Psoriasis is expected to reach US$ 2.5 billion through 2027.

Through 2027, the blue light phototherapy segment is expected to have a market value of US$ 1 Bn

This recent trend is boosting the phototherapy segment. While in the U.S. the growing population of adult women suffering from acne and psoriasis is an important factor driving revenue growth of the phototherapy segment.

The population of adult women is rising with higher rates in North America than in European countries such as Germany, Italy, France and Spain. The growth in women adult acne conditions in North America is mainly due to increase in male hormonal (androgens) levels in females.

Customize this Report

Let us know your requirement to get
100% FREE customization

Complementary therapies to treat psoriasis conditions and combination therapies are recent trends in Western Europe, which are creating a positive impact on the phototherapy segment in the regional market

Complementary therapies such as balneotherapy along with UV radiation is quite popular in Western European countries. Balneotherapy is the oldest treatment method available to treat the psoriasis condition. In this treatment, the patient undergoes a bath in high mineralized brine, which causes a mechanical removal of skin scales and increases the sensitivity of skin to UV radiation.

Combination therapies are set to witness high potential in austerity driven markets in Europe as noted by many clinic managers. Faltering out-of-pocket expenses for a service that is considered as a desire or luxury coupled with a tricky pricing of combination treatments involving a device and a drug are factors successfully helping in generating revenue in the market. This trend is very prominent in countries such as the U.K. and Spain.

Phototherapy Treatment Market Download Report Brochure

Approved by the FDA to treat acne and psoriasis, blue light therapy dominates the North America and Europe phototherapy treatment market

By phototherapy type, blue light therapy dominated the North America and Europe phototherapy treatment market for psoriasis and acne, and is expected to be the most lucrative segment over the forecast period, with a market attractiveness index of 3.3. By the end of 2027, the blue light phototherapy segment is projected to reach more than US$ 1,000 Mn, expanding at a CAGR of 6.7% over the forecast period.

Revenue from the Narrowband UVB phototherapy segment in the North America and Europe phototherapy treatment market for psoriasis and acne is expected to grow 1.9x by 2027 end as compared to that in 2017. The Red Light Phototherapy and Intense Pulsed Light (IPL) Phototherapy segments represent the lowest market attractiveness index of 0.3 each.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Availability of various treatments for acne and psoriasis and declining reimbursement rates are expected to hamper the growth of the phototherapy segment

Various treatments are currently available in the market to treat acne and psoriasis conditions. For instance, to treat acne conditions various drugs are available in the market such as topical/oral antibiotics and retinoid and chemical peels, among others. Due to a lot of available treatment options, physicians prescribe different treatments according to the patient’s skin nature and availability of drugs.

Owing to the many treatment options, very few physicians prescribe phototherapy to patients. Furthermore, availability of non-office based treatments to treat acne and psoriasis conditions has a negative impact on the growth of the phototherapy segment. Furthermore, the decline of reimbursement pay and lack of adequate phototherapy units in the market are projected to hamper revenue growth of the phototherapy segment over the forecast period.

North America and Europe Phototherapy Treatment for Acne and Psoriasis Market – Taxonomy

By Disease Type

  • Psoriasis
    • Guttate Psoriasis
    • Inverse Psoriasis
    • Pustular Psoriasis
    • Erythrodermic Psoriasis
    • Plaque Psoriasis
  • Acne
    • Acne Vulgaris
    • Acne Conglobata
    • Acne Fulminans
    • Gram-Negative Folliculitis
    • Acne Rosacea
    • Pyoderma Faciale

By Phototherapy Type

  • Blue Light Phototherapy
  • Red Light Phototherapy
  • Intense Pulsed Light (IPL) Phototherapy
  • Narrowband UVB Phototherapy
  • Psoralens+Ultravioletlight A (PUVA) Phototherapy

By End User

  • Hospitals
  • Dermatology Clinics/Skin Care Centres
  • Wellness Centres
  • Home Care Settings

By Region

  • North America
  • Western Europe
  • Eastern Europe
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Frequently Asked Questions

The phototherapy treatment market is valued at US$ 530 Million in 2021. The market is likely to grow at a CAGR of 5% through 2026, reaching US$ 675 Million.

Lifespan, UVC Irvine Health, Buffalo Medical Corp. and National Skin Centre are some prominent phototherapy treatment providers in the market

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

    2.3. Phototherapy Treatment Market Overview

3. Medical Bionic Implants & Exoskeletons Market View Point

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

    3.3. Pricing Assumptions

4. North America Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027

    4.1. Introduction

    4.2. Regional Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Trends

    4.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

        4.3.1. U.S.

        4.3.2. Canada

    4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

        4.4.1. U.S.

        4.4.2. Canada

    4.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

        4.5.1. Psoriasis

            4.5.1.1. Guttate Psoriasis

            4.5.1.2. Inverse Psoriasis

            4.5.1.3. Pustular Psoriasis

            4.5.1.4. Erythrodermic Psoriasis

            4.5.1.5. Plaque Psoriasis

        4.5.2. Acne

            4.5.2.1. Acne Vulgaris

            4.5.2.2. Acne Conglobata

            4.5.2.3. Acne Fulminans

            4.5.2.4. Gram-Negative Folliculitis

            4.5.2.5. Acne Rosacea

            4.5.2.6. Pyoderma Faciale

    4.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

        4.6.1. Psoriasis

            4.6.1.1. Guttate Psoriasis

            4.6.1.2. Inverse Psoriasis

            4.6.1.3. Pustular Psoriasis

            4.6.1.4. Erythrodermic Psoriasis

            4.6.1.5. Plaque Psoriasis

        4.6.2. Acne

            4.6.2.1. Acne Vulgaris

            4.6.2.2. Acne Conglobata

            4.6.2.3. Acne Fulminans

            4.6.2.4. Gram-Negative Folliculitis

            4.6.2.5. Acne Rosacea

            4.6.2.6. Pyoderma Faciale

    4.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

        4.7.1. Blue Light Phototherapy

        4.7.2. Red Light Phototherapy

        4.7.3. Intense Pulsed Light (IPL) Phototherapy

        4.7.4. Combination Treatment

        4.7.5. Narrowband UVB Phototherapy

        4.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        4.7.7. Others

    4.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

        4.8.1. Blue Light Phototherapy

        4.8.2. Red Light Phototherapy

        4.8.3. Intense Pulsed Light (IPL) Phototherapy

        4.8.4. Combination Treatment

        4.8.5. Narrowband UVB Phototherapy

        4.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        4.8.7. Others

    4.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

        4.9.1. Hospitals

        4.9.2. Dermatology Clinics/Skin Care Centers

        4.9.3. Wellness Centers

        4.9.4. Home Care Settings 

    4.10. Market Size (US$ Mn) Forecast By End User, 2017-2027

        4.10.1. Hospitals

        4.10.2. Dermatology Clinics/Skin Care Centers

        4.10.3. Wellness Centers

        4.10.4. Home Care Settings

    4.11. Market Attractiveness Analysis

        4.11.1. By Country

        4.11.2. By Disease Type

        4.11.3. By Phototherapy

        4.11.4. By End User

5. Western Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027 

    5.1. Introduction

    5.2. Regional Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

        5.2.3. Trends

    5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

        5.3.1. Germany

        5.3.2. United Kingdom

        5.3.3. France

        5.3.4. Italy

        5.3.5. Spain

        5.3.6. Nordics

        5.3.7. BENELUX

        5.3.8. Rest of Western Europe

    5.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

        5.4.1. Germany

        5.4.2. United Kingdom

        5.4.3. France

        5.4.4. Italy

        5.4.5. Spain

        5.4.6. Nordics

        5.4.7. BENELUX

        5.4.8. Rest of Western Europe

    5.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

        5.5.1. Psoriasis

            5.5.1.1. Guttate Psoriasis

            5.5.1.2. Inverse Psoriasis

            5.5.1.3. Pustular Psoriasis

            5.5.1.4. Erythrodermic Psoriasis

            5.5.1.5. Plaque Psoriasis

        5.5.2. Acne

            5.5.2.1. Acne Vulgaris

            5.5.2.2. Acne Conglobata

            5.5.2.3. Acne Fulminans

            5.5.2.4. Gram-Negative Folliculitis

            5.5.2.5. Acne Rosacea

            5.5.2.6. Pyoderma Faciale

    5.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

        5.6.1. Psoriasis

            5.6.1.1. Guttate Psoriasis

            5.6.1.2. Inverse Psoriasis

            5.6.1.3. Pustular Psoriasis

            5.6.1.4. Erythrodermic Psoriasis

            5.6.1.5. Plaque Psoriasis

        5.6.2. Acne

            5.6.2.1. Acne Vulgaris

            5.6.2.2. Acne Conglobata

            5.6.2.3. Acne Fulminans

            5.6.2.4. Gram-Negative Folliculitis

            5.6.2.5. Acne Rosacea

            5.6.2.6. Pyoderma Faciale

    5.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

        5.7.1. Blue Light Phototherapy

        5.7.2. Red Light Phototherapy

        5.7.3. Intense Pulsed Light (IPL) Phototherapy

        5.7.4. Combination Treatment

        5.7.5. Narrowband UVB Phototherapy

        5.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        5.7.7. Others

    5.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

        5.8.1. Blue Light Phototherapy

        5.8.2. Red Light Phototherapy

        5.8.3. Intense Pulsed Light (IPL) Phototherapy

        5.8.4. Combination Treatment

        5.8.5. Narrowband UVB Phototherapy

        5.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        5.8.7. Others

    5.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

        5.9.1. Hospitals

        5.9.2. Dermatology Clinics/Skin Care Centers

        5.9.3. Wellness Centers

        5.9.4. Home Care Settings 

    5.10. Market Size (US$ Mn) Forecast By End User, 2017-2027

        5.10.1. Hospitals

        5.10.2. Dermatology Clinics/Skin Care Centers

        5.10.3. Wellness Centers

        5.10.4. Home Care Settings

    5.11. Market Attractiveness Analysis

        5.11.1. By Country

        5.11.2. By Disease Type

        5.11.3. By Phototherapy

        5.11.4. By End User

6. Eastern Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027

    6.1. Introduction

    6.2. Regional Market Dynamics

        6.2.1. Drivers

        6.2.2. Restraints

        6.2.3. Trends

    6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

        6.3.1. Russia

        6.3.2. Poland

        6.3.3. Rest of Eastern Europe

    6.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

        6.4.1. Russia

        6.4.2. Poland

        6.4.3. Rest of Eastern Europe

    6.5. Historical Market Size (US$ Mn) Analysis By Disease Type, 2012-2016

        6.5.1. Psoriasis

            6.5.1.1. Guttate Psoriasis

            6.5.1.2. Inverse Psoriasis

            6.5.1.3. Pustular Psoriasis

            6.5.1.4. Erythrodermic Psoriasis

            6.5.1.5. Plaque Psoriasis

        6.5.2. Acne

            6.5.2.1. Acne Vulgaris

            6.5.2.2. Acne Conglobata

            6.5.2.3. Acne Fulminans

            6.5.2.4. Gram-Negative Folliculitis

            6.5.2.5. Acne Rosacea

            6.5.2.6. Pyoderma Faciale

    6.6. Market Size (US$ Mn) Forecast By Disease Type, 2017-2027

        6.6.1. Psoriasis

            6.6.1.1. Guttate Psoriasis

            6.6.1.2. Inverse Psoriasis

            6.6.1.3. Pustular Psoriasis

            6.6.1.4. Erythrodermic Psoriasis

            6.6.1.5. Plaque Psoriasis

        6.6.2. Acne

            6.6.2.1. Acne Vulgaris

            6.6.2.2. Acne Conglobata

            6.6.2.3. Acne Fulminans

            6.6.2.4. Gram-Negative Folliculitis

            6.6.2.5. Acne Rosacea

            6.6.2.6. Pyoderma Faciale

    6.7. Historical Market Size (US$ Mn) Analysis By Phototherapy, 2012-2016

        6.7.1. Blue Light Phototherapy

        6.7.2. Red Light Phototherapy

        6.7.3. Intense Pulsed Light (IPL) Phototherapy

        6.7.4. Combination Treatment

        6.7.5. Narrowband UVB Phototherapy

        6.7.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        6.7.7. Others

    6.8. Market Size (US$ Mn) Forecast By Phototherapy, 2017-2027

        6.8.1. Blue Light Phototherapy

        6.8.2. Red Light Phototherapy

        6.8.3. Intense Pulsed Light (IPL) Phototherapy

        6.8.4. Combination Treatment

        6.8.5. Narrowband UVB Phototherapy

        6.8.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        6.8.7. Others

    6.9. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

        6.9.1. Hospitals

        6.9.2. Dermatology Clinics/Skin Care Centers

        6.9.3. Wellness Centers

        6.9.4. Home Care Settings 

    6.10. Market Size (US$ Mn) Forecast By End User, 2017-2027

        6.10.1. Hospitals

        6.10.2. Dermatology Clinics/Skin Care Centers

        6.10.3. Wellness Centers

        6.10.4. Home Care Settings

    6.11. Market Attractiveness Analysis

        6.11.1. By Country

        6.11.2. By Disease Type

        6.11.3. By Phototherapy

        6.11.4. By End User

7. Forecast Factors: Relevance and Impact

8. Forecast Assumptions

9. Competition Landscape

    9.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        9.1.1. Lifespan

        9.1.2. UC Irvine Health

        9.1.3. Buffalo Medical Group

        9.1.4. Blackrock Clinic Limited

        9.1.5. The Private Phototherapy Clinic Ltd

        9.1.6. National Skin Centre

        9.1.7. Massachusetts General Hospital

10. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Region

    10.1. Historical Market Size (US$ Mn) Analysis By Region, 2012-2016

        10.1.1. North America

        10.1.2. Western Europe

        10.1.3. Eastern Europe

    10.2. Market Size (US$ Mn) Forecast By Region, 2017-2027

        10.2.1. North America

        10.2.2. Western Europe

        10.2.3. Eastern Europe

    10.3. Market Attractiveness Analysis By Region

11. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Disease

    11.1. Introduction/Key Finding

    11.2. Historical Market Size (US$ Mn) Analysis By Disease, 2012-2016

        11.2.1. Psoriasis

            11.2.1.1. Guttate Psoriasis

            11.2.1.2. Inverse Psoriasis

            11.2.1.3. Pustular Psoriasis

            11.2.1.4. Erythrodermic Psoriasis

            11.2.1.5. Plaque Psoriasis

        11.2.2. Acne

            11.2.2.1. Acne Vulgaris

            11.2.2.2. Acne Conglobata

            11.2.2.3. Acne Fulminans

            11.2.2.4. Gram-Negative Folliculitis

            11.2.2.5. Acne Rosacea

            11.2.2.6. Pyoderma Faciale

    11.3. Market Size (US$ Mn) Forecast By Disease, 2017-2027

        11.3.1. Psoriasis

            11.3.1.1. Guttate Psoriasis

            11.3.1.2. Inverse Psoriasis

            11.3.1.3. Pustular Psoriasis

            11.3.1.4. Erythrodermic Psoriasis

            11.3.1.5. Plaque Psoriasis

        11.3.2. Acne

            11.3.2.1. Acne Vulgaris

            11.3.2.2. Acne Conglobata

            11.3.2.3. Acne Fulminans

            11.3.2.4. Gram-Negative Folliculitis

            11.3.2.5. Acne Rosacea

            11.3.2.6. Pyoderma Faciale

    11.4. Market Attractiveness Analysis By Disease

12. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By Phototherapy 

    12.1. Introduction/Key Finding

    12.2. Historical Market Size (US$ Mn) Analysis By Mode, 2012-2016

        12.2.1. Blue Light Phototherapy

        12.2.2. Red Light Phototherapy

        12.2.3. Intense Pulsed Light (IPL) Phototherapy

        12.2.4. Combination Treatment

        12.2.5. Narrowband UVB Phototherapy

        12.2.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        12.2.7. Others

    12.3. Market Size (US$ Mn) Forecast By Mode, 2017-2027

        12.3.1. Blue Light Phototherapy

        12.3.2. Red Light Phototherapy

        12.3.3. Intense Pulsed Light (IPL) Phototherapy

        12.3.4. Combination Treatment

        12.3.5. Narrowband UVB Phototherapy

        12.3.6. Psoralens+Ultraviolet light A (PUVA) Phototherapy

        12.3.7. Others

    12.4. Market Attractiveness Analysis By Phototherapy

13. North America and Europe Phototherapy Treatment Market for Psoriasis & Acne Analysis 2012–2016 and Forecast 2017–2027, By End User 

    13.1. Introduction/Key Finding

    13.2. Historical Market Size (US$ Mn) Analysis By End User, 2012-2016

        13.2.1. Hospitals

        13.2.2. Dermatology Clinics/Skin Care Centers

        13.2.3. Wellness Centers

        13.2.4. Home Care Settings 

    13.3. Market Size (US$ Mn) Forecast By End User, 2017-2027

        13.3.1. Hospitals

        13.3.2. Dermatology Clinics/Skin Care Centers

        13.3.3. Wellness Centers

        13.3.4. Home Care Settings 

    13.4. Market Attractiveness Analysis By End User

14. Assumptions and Acronyms Used

15. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: North America Phototherapy Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 2: North America Phototherapy Treatment Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 3: North America Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 4: North America Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 5: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 6: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 7: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 8: Western Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 9: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Country

Table 10: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease Type

Table 11: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 12: Eastern Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Table 13: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Region

Table 14: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Disease

Table 15: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By Phototherapy

Table 16: North America and Europe Phototherapy Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2027, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: North America and Europe Phototherapy Market Value Analysis and Forecast, 2017–2027 (US$ Mn)

Figure 2: North America Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027 

Figure 3: North America Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027 

Figure 4: North America Phototherapy Treatment Market Size Analysis (%) 2012–2016

Figure 5: North America Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027

Figure 6: North America Phototherapy Treatment Market Attractiveness Analysis, By Country

Figure 7: North America Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy

Figure 8: North America Phototherapy Treatment Market Attractiveness Analysis, By Disease Type

Figure 9: North America Phototherapy Treatment Market Attractiveness Analysis, By End User

Figure 10: Western Europe Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027 

Figure 11: Western Europe Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027 

Figure 12: Western Europe Phototherapy Treatment Market Size Analysis (%), 2012–2016

Figure 13: Western Europe Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027

Figure 14: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Country

Figure 15: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy

Figure 16: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By Disease Type

Figure 17: Western Europe Phototherapy Treatment Market Attractiveness Analysis, By End User

Figure 18: Acne and Psoriasis Prevalence Rates in Eastern Europe Region, 2015

Figure 19: Psoriasis Patients in Eastern Europe Region, 2010 & 2015

Figure 20: Eastern Europe Phototherapy Treatment Market Share Analysis (%) By Country, 2017–2027 

Figure 21: Eastern Europe Phototherapy Treatment Market Y-o-Y Growth (%) By Country, 2017–2027 

Figure 22: Eastern Europe Phototherapy Treatment Market Size Analysis (%), 2012–2016

Figure 23: Eastern Europe Phototherapy Treatment Market Y-o-Y Growth (%), 2017–2027

Figure 24: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Country

Figure 25: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy 

Figure 26: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By Disease Type

Figure 27: Eastern Europe Phototherapy Treatment Market Attractiveness Analysis, By End User

Figure 28: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By Region

Figure 29: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, Disease

Figure 30: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By Phototherapy

Figure 31: North America and Europe Phototherapy Treatment Market Attractiveness Analysis, By End User

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Hemophilia Treatment Market

Published : February 2022

Healthcare

Keloid Treatment Market

Published : October 2017

Healthcare

Bronchitis Treatment Market

Published : March 2016

Healthcare

Dry Eye Syndrome Treatment Market

Published : February 2022

Google translate

Phototherapy Treatment Market